Clinical trials
Active, not recruiting Phase 3 Heart Failure trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tenax Therapeutics, Inc. | 2 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Conrado Roberto Hoffmann Filho | 1 |
| Hospital Clinic of Barcelona | 1 |
| National Institute of Cardiology, Warsaw, Poland | 1 |
| Novo Nordisk A/S | 1 |
| Pulnovo Medical (Wuxi) Co., Ltd. | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 9 |
| Hypertension, Pulmonary | 2 |
| ST Elevation Myocardial Infarction | 2 |
| Acute Coronary Syndrome | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Cardiovascular Diseases | 1 |
| Death | 1 |
| Diabetes Mellitus | 1 |
| Embolism | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.